CSPC Pharmaceutical Group Limited (HKG:1093)

CSPC Pharmaceutical Group Revenue

CSPC Pharmaceutical Group had revenue of 12.13B CNY in the quarter ending June 30, 2026, with 93.80% growth. This brings the company's revenue in the last twelve months to 31.33B, up 20.50% year-over-year. In the year 2025, CSPC Pharmaceutical Group had annual revenue of 26.01B, down -10.35%.

• Revenue (ttm): 31.33B CNY
• Revenue Growth: +20.50%
• P/S Ratio: 3.06
• Revenue / Employee: 1.68M CNY
• Employees: 18,626
• Market Cap: 110.73B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	26.01B	-3.00B	-10.35%
Dec 31, 2024	29.01B	-2.44B	-7.76%
Dec 31, 2023	31.45B	513.21M	1.66%
Dec 31, 2022	30.94B	3.07B	11.02%
Dec 31, 2021	27.87B	2.92B	11.73%

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 5, 2026

Data Sources Report a data error